Unbound MEDLINE

Differential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis. Journal of immunology (Baltimore, Md. : 1950) [J Immunol] Journal article

 
TitleDifferential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis.
Author(s)Wüthrich M, Fisette PL, Filutowicz HI, Klein BS 
InstitutionDepartment of Pediatrics, University Hospital and Clinics, University of Wisconsin Medical School, 600 Highland Avenue, Madison, WI 53792, USA. mwuethri@wisc.edu
SourceJ Immunol 2006 May 1; 176(9):5538-47.
MeSHAnimals
Antigen Presentation
Antigens, CD40
Blastomyces
Blastomycosis
Bone Marrow
CD4-Positive T-Lymphocytes
CD40 Ligand
CD8-Positive T-Lymphocytes
Cell Differentiation
Cell Polarity
Cells, Cultured
Dendritic Cells
Mice
Mice, Inbred C57BL
Mice, Knockout
Research Support, U.S. Gov't, P.H.S.
T-Lymphocyte Subsets
Vaccination
AbstractCell-mediated immunity and production of type 1 cytokines are the main defenses against pathogenic fungi. Ligation of CD40 by CD40L on T cells is critical for the induction of these immune responses in vivo. We explored the role of CD40/CD40L interactions in vaccine immunity to Blastomyces dermatitidis by immunizing CD40(-/-) and CD40L(-/-) mice and analyzing their resistance to reinfection in a murine pulmonary model. In the absence of CD40 or CD40L, CD4(+) cells failed to get primed or produce type 1 cytokine and impaired the generation of CD8(+) T1 cells. The CD8(+) T cell defect was not due to regulatory T cells or impaired APC maturation or Ag presentation to T cells. If CD4(+) cells were first eliminated, vaccination of CD40(-/-) and CD40L(-/-) mice restored priming of CD8(+) cells, type 1 cytokine production, and resistance. Hence, CD4(+) and CD8(+) cells differ sharply in their requirement for CD40/CD40L interaction during the generation of antifungal immunity. Despite the plasticity of T cell subsets in vaccine immunity, in absence of CD40/CD40L interaction, CD4(+) cells may impede the priming of CD8(+) cells at the cost of host survival against a lethal infectious disease.
Languageeng
Pub Type(s)Journal Article
PubMed ID16622023
  
Advertise on this site.